Volume 34, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Hybridoma cell lines secreting monoclonal antibodies against the Tulahuén strain of were produced by the fusion of SP2/O-Ag14 myeloma cells with spleen cells from mice immunized with irradiated metacyclic trypomastigotes. Twenty of the monoclonals synthesized by the hybridomas were identified as IgM, 2 as IgG, 10 as IgG, 3 as IgG, 4 as IgG, 1 as IgE, and 1 as IgA. Twenty-three of these antibodies had κ light chains and 18 showed λ chains. Twelve of the monoclonals agglutinated metacyclic trypomastigotes without additional concentration and 4 of these precipitated antigens in extracts of metacyclic or epimastigote stages. One monoclonal precipitated an epimastigote antigen, while another reacted with a metacyclic antigen, and 2 antibodies formed precipitin lines with antigens of both stages. Agglutinin assays performed to characterize surface antigenic specificities of the 12 monoclonal antibodies showed that 2 reacted only with the metacyclic stage of the Tulahuén strain. Two monoclonals agglutinated both metacyclic trypomastigotes and epimastigotes of the Tulahuén strains. Three antibodies caused clumping of metacyclics and epimastigotes of the Tulahuén, Raccoon V, and Corpus Christi strains of , while a fourth also reacted with bloodstream trypomastigotes. One monoclonal detected identical epitopes on metacyclics and epimastigotes of and epimastigotes of , while 2 antibodies reacted with metacyclics, epimastigotes, and bloodstream trypomastigotes of the Tulahuén and Raccoon V strains and the bloodstream stage of . One antibody agglutinated all stages and strains of , and which were tested. None of the 12 monoclonals reacted with amastigotes of . The precipitin reactions between the monoclonals and parasite extracts indicate that more than 1 identical epitope is present on each precipitating antigen molecule, while agglutinin analyses demonstrated antigenic specificities and relationships among stages, strains, and species of these trypanosomes.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error